Table 2.

The cumulative incidence of psychiatric adverse events (AEs) following COVID-19 vaccination.

Diseases	Vaccination	Total number	One week				Two weeks				One month				Three months
			event	I	95% CI	p	event	I	95% CI	p	event	I	95% CI	p	event	I	95% CI	p
Schizophrenia	No	308,354	5	0.16	0.02–0.30	0.017	7	0.23	0.06–0.40	0.018	24	0.78	0.47–1.09	<0.001	61	1.98	1.48–2.47	<0.001
	Yes	1,718,999	6	0.03	0.01–0.06		12	0.07	0.03–0.11		26	0.15	0.09–0.21		88	0.51	0.40–0.62
Depression	No	308,354	26	0.84	0.52–1.17	0.290	54	1.75	1.28–2.22	0.097	142	4.61	3.85–5.36	0.026	439	14.24	12.91–15.57	<0.001
	Yes	1,718,999	184	1.07	0.92–1.23		386	2.25	2.02–2.47		965	5.61	5.26–5.97		3145	18.30	17.66–18.93
Bipolar disorder	No	308,354	2	0.06	0.00–0.15	0.655	4	0.13	0.00–0.26	0.517	9	0.29	0.10–0.48	0.299	43	1.39	0.98–1.81	0.002
	Yes	1,718,999	8	0.05	0.01–0.08		15	0.09	0.04–0.13		35	0.20	0.14–0.27		136	0.79	0.66–0.92
Anxiety, dissociative, stress-related, somatoform disorders	No	308,354	48	1.56	1.12–2.00	0.014	95	3.08	2.46–3.70	<0.001	208	6.75	5.83–7.66	<0.001	625	20.27	18.68–21.86	<0.001
	Yes	1,718,999	389	2.26	2.04–2.49		766	4.46	4.14–4.77		1641	9.55	9.08–10.01		4884	28.41	27.62–29.21
Sleep disorders	No	308,354	29	0.94	0.60–1.28	<0.001	58	1.88	1.40–2.36	<0.001	132	4.28	3.55–5.01	<0.001	376	12.19	10.96–13.43	<0.001
	Yes	1,718,999	330	1.92	1.71–2.13		709	4.12	3.82–4.43		1544	8.98	8.53–9.43		4960	28.85	28.05–29.66
Eating disorders	No	308,354	2	0.06	0.00–0.15	0.169	2	0.06	0.00–0.15	0.349	3	0.10	0.00–0.21	0.735	10	0.32	0.12–0.53	0.724
	Yes	1,718,999	3	0.02	0.00–0.04		6	0.03	0.01–0.06		14	0.08	0.04–0.12		51	0.30	0.22–0.38
Sexual disorders	No	308,354	0	0.00	0.00–0.00	1.000	0	0.00	0.00–0.00	0.617	0	0.00	0.00–0.00	0.154	1	0.03	0.00–0.10	0.007
	Yes	1,718,999	1	0.01	0.00–0.02		8	0.05	0.01–0.08		16	0.09	0.05–0.14		46	0.27	0.19–0.34

I cumulative incidence, CI confidence interval.